의약품 관련 법령
Slowly Progressive, Low-Pr-ence Rare Diseases with Substrate Deposition That Results from Single Enzyme Defects: Providing Evidence of Effectiveness for Replacement or Corrective Therapies Guidance for Industry
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-07-31 | 조회수 | 895 |
국가정보 | 북 아메리카>미국 | ||
출처 | FDA | ||
원문 | https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM614641.pdf | ||
첨부파일 |
Slowly Progressive, Low-Prevalence Rare Diseases with Substrate Deposition That Results from Single Enzyme Defects: Providing Evidence of Effectiveness for Replacement or Corrective Therapies Guidance for Industry
- 이전글 Use of Liquids and/or Soft Foods as Vehicles for Drug Administration: General Considerations for Selection and In Vitro Methods for Product Quality Assessments
- 다음글 Abbreviated New Drug Application Submissions--Amendments to Abbreviated New Drug Applications Under the Generic Drug User Fee Act; Guidance for Industry